Pharma Quality Transformation Future Roadmap for 2035

Quality Transformation Future Roadmap for 2035
Reading Time: < 1 minute
Project Lead/Expert: Peyman Moh
Project Scope: Strategy
Client/Partners: Confidential
Status: Delivered
Date: 2022-2023
Key Objectives:

  • Develop a comprehensive quality roadmap for 2035 using foresight-driven innovation methodology.
  • Identify and prioritize relevant business signals, drivers, and potential opportunities through extensive workshops and stakeholder training.
  • Create plausible and provocative forecasts for the next 10-15 years, highlighting key partnerships, challenges, and capabilities.
  • Design compelling future scenarios and integrated roadmaps to build the required capabilities for the envisioned future.
  • Mobilize cross-functional change networks and provide recommendations for new partnerships and capabilities.


The Quality Future Roadmap project was initiated to establish a strategic vision for the year 2035, focusing on the quality domain for one of major global pharmaceutical compny. Utilizing the Future-Back thinking methodology, the project was structured into a series of sprints, each with clearly defined activities and deliverables. The initial phase involved understanding existing strategies and preparing stakeholders. Subsequent sprints were dedicated to exploring current trends, forecasting future challenges, designing scenarios, and defining the necessary steps to realize the vision. Throughout the project, a series of workshops with stakeholders ensured a collaborative approach, while ongoing analysis of signals and drivers informed the creation of a transformation plan that aligns with the envisioned future of quality in the pharmaceutical industry.

Key Outcomes:

  • A detailed and validated roadmap outlining the progression towards the 2035 vision for the organization’s quality division.
  • A transformation plan supporting the Quality 4.0 mindset, including strategic initiatives and capability development.
  • A set of compelling future scenarios to guide the organization in preparing for foreseeable changes and challenges.
  • Identification of new partnership opportunities and a framework for cross-functional collaboration to drive innovation and change.
  • Comprehensive benchmarks and SWOT analysis reports providing insights beyond the pharmaceutical sector, ensuring a robust strategy aligned with broader industry standards.

Peyman Moh, a seasoned leader with over 20 years of experience in digital health and innovation, excels in transforming foresight into impactful realities. As the former Director of Digital Health & Innovation at GSK and founder of Foretell Innovation Lab, he has spearheaded major projects, established innovation accelerators, and provided advisory services. Renowned for his strategic foresight and ability to foster ecosystem collaborations, Peyman's expertise in future-back thinking and innovation lifecycle management positions him as a pivotal figure in navigating the rapidly evolving innovation landscape.